Return to the Home Page
View the Site Map

Search this Site using

    This Site
    The WWW
Search for Vital Mold Information and Resources
Anti-fungal drug  
Posted by Susan Lillard  
Sunday, 03 October 2004

February 25, 2004 09:04 AM EST

Indevus Initiates Phase I Clinical Trial of Aminocandin for Systemic Fungal Infections

LEXINGTON, Mass.--(BUSINESS WIRE)--Feb. 25, 2004--Indevus Pharmaceuticals, Inc. (NASDAQ: IDEV) today announced the initiation of a Phase I clinical trial with aminocandin, a member of a new class of anti-fungal compounds under development for the treatment of a broad spectrum of systemic, invasive infections. This trial will test the safety and tolerability of escalating single doses of aminocandin administered intravenously in healthy volunteers. Results of the trial are expected in the second half of 2004.


Additional Articles
Display # 
 Date Item Title Author
3 Oct  Anti-fungal drug -
<< Start < Previous 1 Next > End >>
Results 1 - 1 of 1
  Spiritual Definition (2 items)
  Mold and Sick Buildings (2 items)
  Mold and the Environment (1 items)
  Mold and Schools (3 items)
  Mold and Insurance (4 items)
  Mold Stories (40 items)
  Strange Stories (11 items)
  Coping with the Loss of Loved Ones (3 items)
  Additional Articles
Home | Glossary | Current Headlines | Resources | Discussion Board | Products | Events | Contact Us Now! | Disclaimer
  © 2003 - All Rights Reserved - Atlanta Web Design - Atlanta Internet Marketing
  The contents of this site may not be copied in any matter unless permission is granted by the author.